Apple Commits Over $30 Billion to U.S. Manufacturing in Major Broadcom Deal
The largest investment under Apple’s American Manufacturing Program.
Already have an account? Sign in.
The largest investment under Apple’s American Manufacturing Program.
Stronger AI server demand, NVIDIA integration, and enterprise focus drive optimism amid supply constraints.
Tvardi’s new drug TTI-109 showed strong early results, fewer side effects, and potential in autoimmune diseases, boosting investor confidence.
Positive six-month COMP360 results trigger analyst upgrades and higher price targets for Compass Pathways. Strong durability data clears path to potential 2027 FDA approval in treatment-resistant depression.